Filing Details

Accession Number:
0001209191-10-030744
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-27 13:00:00
Reporting Period:
2010-05-25
Filing Date:
2010-05-27
Accepted Time:
2010-05-27 14:07:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472595 Accretive Health Inc. AH Services-Management Services (8741) 020698101
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1262312 Accretive Investors Sbic Lp 51 Madison Avenue
31St Floor
New York NY 10010
No No Yes No
1492319 Accretive Associates Sbic, Llc 51 Madison Avenue
31St Floor
New York NY 10010
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-25 20,908,996 $0.00 20,908,996 No 4 C Indirect See Footnote
Common Stock Disposition 2010-05-25 865,520 $11.28 20,043,476 No 4 S Indirect See Footnote
Common Stock Disposition 2010-05-25 129,828 $11.28 19,913,648 No 4 S Indirect See Footnote
Common Stock Acquisiton 2010-05-25 603,218 $12.00 20,516,866 No 4 J Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 J Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2010-05-25 15,927 $0.00 19,136,400 $0.00
Common Stock Series D Convertible Preferred Stock Disposition 2010-05-25 452,193 $0.00 1,772,596 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series A Convertible Preferred Stock represented herein converted into 1,201.5069 shares of common stock, par value $0.01 per share, of the Issuer (the "Common Stock"), and had no expiration date. Each share of Series D Convertible Preferred Stock represented herein converted into 3.92 shares of Common Stock and had no expiration date.
  2. Accretive Investors SBIC, L.P. directly beneficially owns the reported securities. Accretive Associates SBIC, LLC is the general partner of Accretive Investors SBIC, L.P. J. Michael Cline is the managing member of Accretive Associates SBIC, LLC and serves on the board of directors of Accretive Health, Inc. Each of Accretive Investors SBIC, L.P. and Accretive Associates SBIC, LLC disclaim beneficial ownership of the reported securities except to the extent of any pecuniary interest therein, if any.
  3. Reflects shares of Common Stock received in satisfaction of a liquidation preference required to be made to Accretive Investors SBIC, L.P. in connection with the close of the Issuer's initial public offering.